Pasadena Private Wealth’s Eli Lilly LLY Stock Holding History

Pasadena Private Wealth’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.3M	Buy	1,087 +145	+15%	+$148K	0.17%	78
2026 Q1	$866K	Sell	942 -1,791	-66%	-$1.82M	0.12%	95
2025 Q4	$2.94M	Hold	2,733	–	–	0.4%	41
2025 Q3	$2.08M	Buy	2,733 +323	+13%	+$240K	0.3%	49
2025 Q2	$1.88M	Buy	2,410 +1,624	+207%	+$1.26M	0.32%	40
2025 Q1	$649K	Hold	786	–	–	0.13%	83
2024 Q4	$607K	Buy	786 +1	+0.1%	+$828	0.12%	79
2024 Q3	$695K	Sell	785 -6	-0.8%	-$5.39K	0.15%	72
2024 Q2	$716K	Buy	791 +10	+1%	+$8K	0.17%	62
2024 Q1	$608K	Hold	781	–	–	0.14%	74
2023 Q4	$455K	Hold	781	–	–	0.11%	81
2023 Q3	$419K	Buy	781 +30	+4%	+$15.5K	0.13%	58
2023 Q2	$352K	Hold	751	–	–	0.1%	68
2023 Q1	$258K	Hold	751	–	–	0.07%	77
2022 Q4	$275K	Sell	751 -24	-3%	-$8.51K	0.08%	74
2022 Q3	$251K	Hold	775	–	–	0.09%	68
2022 Q2	$251K	Hold	775	–	–	0.09%	66
2022 Q1	$222K	Hold	775	–	–	0.07%	81
2021 Q4	$214K	Buy	+775	New	+$196K	0.07%	98

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pasadena Private Wealth's LLY Position: Q2 2026 in Review

Pasadena Private Wealth increased its Eli Lilly (LLY) stake by 15% in Q2 2026, buying an estimated $148K and bringing the position to 1,087 shares worth $1.3M. The position accounts for 0.17% of the portfolio, ranked #78.

Pasadena Private Wealth first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.94M in Q4 2025. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Pasadena Private Wealth held 1,087 shares of Eli Lilly worth $1.3M as of Q2 2026.
Pasadena Private Wealth bought 145 Eli Lilly shares in Q2 2026, an estimated $148K.
Eli Lilly made up 0.17% of Pasadena Private Wealth's portfolio in Q2 2026, its #78 holding.
Pasadena Private Wealth first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
Pasadena Private Wealth's Eli Lilly position peaked at $2.94M in Q4 2025.
4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Pasadena Private Wealth's 13F filing for Q2 2026, filed 11 Aug 2026.